METFORMIN IN OVERWEIGHT ADOLESCENTS

二甲双胍在超重青少年中的应用

• 批准号: 7607253
• 负责人: Carine M Lenders
• 金额: $ 2.46万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607253
• 关键词: Adolescent; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Metformin; Obesity; Overweight; Pharmaceutical Preparations; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Weight; glucophage; non-diabetic

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is to find out if the drug metformin (Glucophage XR, Bristol -Myers Squibb Co. Inc) will help obese, non-diabetic adolescents lose weight. We will find this out by comparing one group of subjects that will take metformin to another group who will not take the drug.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究是要找出药物二甲双胍（Glucophage XR，Bristol -Myers Squibb Co. Inc）是否会帮助肥胖，非糖尿病青少年减肥。我们将通过比较一组将二甲双胍与不会服用该药物的组的受试者进行比较来发现这一点。